Rebrain.

Rebrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases

Medical Device ยท Nouvelle-Aquitaine

About

Rebrain offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated.

Details

  • Website: https://rebrain.eu
  • Founded: 2021
  • Company Size: 24 employees
  • Headquarters: Pessac, Nouvelle-Aquitaine